Skip to main content

LAWSUITS FILED AGAINST ENPH, CODX and BKD - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS

NEW YORK, NY / ACCESSWIRE / August 5, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

Enphase Energy, Inc. (NASDAQ:ENPH)

CONTACT JAKUBOWITZ ABOUT ENPH:
https://claimyourloss.com/securities/enphase-energy-inc-loss-submission-form/?id=8377&from=1

Class Period: February 26, 2019 - June 17, 2020

Lead Plaintiff Deadline: August 17, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) its revenues, both U.S. and international, were inflated; (2) the Company engaged in improper deferred revenue accounting practices; (3) the Company's reported base points expansion in gross margins were overstated; and (4) as a result of the foregoing, Defendants' public statements were materially false and misleading at all relevant times.

Co-Diagnostics, Inc. (NASDAQ:CODX)

CONTACT JAKUBOWITZ ABOUT CODX:
https://claimyourloss.com/securities/co-diagnostics-inc-loss-submission-form/?id=8377&from=1

Class Period: February 25, 2020 - May 15, 2020

Lead Plaintiff Deadline: August 17, 2020

According to the filed complaint, Co-Diagnostics and its directors and officers (including PhD-level scientists who should know better) made continual, knowing, and willful misstatements about the Company's main product, a Covid-19 diagnostic test. These misstatements had the effect of pumping up the price of Co-Diagnostics' stock, while Company officers and directors exercised low-priced options and dumped their stock into the market. Co-Diagnostics' fraudulent misstatements displayed a disregard for basic scientific principles and caused investors to lose millions of dollars.

Brookdale Senior Living Inc. (NYSE:BKD)

CONTACT JAKUBOWITZ ABOUT BKD:
https://claimyourloss.com/securities/brookdale-senior-living-inc-loss-submission-form/?id=8377&from=1

Class Period: August 10, 2016 - April 29, 2020

Lead Plaintiff Deadline: August 24, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Brookdale's financial performance was sustained by, among other things, the Company's purposeful understaffing of its senior living communities; (ii) the foregoing conduct subjected Brookdale to an increased risk of litigation and, once revealed, was foreseeably likely to have a material negative impact on the Company's financial results and reputation; (iii) as a result, the Company's financial results were unsustainable; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

SOURCE: Jakubowitz Law



View source version on accesswire.com:
https://www.accesswire.com/600398/LAWSUITS-FILED-AGAINST-ENPH-CODX-and-BKD--JAKUBOWITZ-LAW-PURSUES-SHAREHOLDERS-CLAIMS

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.